Chabiotech Co., Ltd.
🇰🇷South Korea
Clinical Trials
7
Active:1
Completed:5
Trial Phases
1 Phases
Phase 1:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (100.0%)Phase 1 Clinical Trial of CordSTEM-ST
Phase 1
Completed
- Conditions
- Premature Ovarian Insufficiency
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- CHABiotech CO., Ltd
- Target Recruit Count
- 6
- Registration Number
- NCT06578039
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer
Phase 1
Completed
- Conditions
- Solid Tumor
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- CHABiotech CO., Ltd
- Target Recruit Count
- 6
- Registration Number
- NCT04557306
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain
Phase 1
Completed
- Conditions
- Chronic Low-back PainDisc Degeneration
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- CHABiotech CO., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT04530071
- Locations
- 🇰🇷
CHA Bundand Medical Center, Seongnam-si, Korea, Republic of
Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease
Phase 1
Active, not recruiting
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- CHABiotech CO., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT02899091
- Locations
- 🇰🇷
Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction
Phase 1
Completed
- Conditions
- Cerebral Infarction
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- CHABiotech CO., Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT02378974
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found